Congenital Myasthenic Syndrome Clinical Trials

Find Congenital Myasthenic Syndrome Clinical Trials Near You

Multicenter, Multinational, Natural History Study in Participants With Congenital Myasthenic Syndromes Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Status: Recruiting
Location: See all (31) locations...
Study Type: Observational
SUMMARY

Participants will attend up to 4 study visits to collect clinical assessments. The assessments will evaluate participants' symptoms and quality of life to understand disease activity in patients with CMS due to mutations in DOK7, MUSK, AGRN, or LRP4. More information can be found here: https://clinicaltrials.argenx.com/cms

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: f
View:

• Can understand the requirements of the study and can provide written informed consent/assent, and willingness and ability to comply with the study protocol procedures

• Is male or female and aged ≥2 years at the time of providing informed consent/assent

• Has a diagnosis of CMS due to biallelic pathogenic mutations in DOK7 or any pathogenic mutations in MUSK, AGRN, or LRP4

• Has a total Quantitative Myasthenia Gravis (QMG) score of ≥3 (applies only to participants aged ≥6 years)

• For participants taking oral beta agonists (eg, albuterol, salbutamol, ephedrine), participant must have been receiving the medication for ≥3 months before screening/baseline

Locations
United States
California
UC Davis Health - UC Davis Health Midtown Ambulatory Care Center
RECRUITING
Sacramento
Illinois
Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital
RECRUITING
Chicago
Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital
RECRUITING
O'fallon
Massachusetts
Harvard Medical School - Boston Children's Hospital
RECRUITING
Boston
Ohio
Ohio State Martha Moorehouse
RECRUITING
Columbus
Pennsylvania
The Children's Hospital of Philadelphia (CHOP)
RECRUITING
Philadelphia
Other Locations
Austria
Medical University of Vienna
RECRUITING
Vienna
Belgium
Hopital Universitaire de Bruxelles/ Academisch Ziekenhuis Brussel
RECRUITING
Brussels
Brazil
Pseg Centro De Pesquisa ClinicaS.A
RECRUITING
São Paulo
Canada
The Children's Hospital of Eastern (CHEO), Ottawa
RECRUITING
Ottawa
The Ottawa Hospital - Civic Campus
RECRUITING
Ottawa
France
CHU Bordeaux - Groupe Hospitalier Pellegrin - Neurology
RECRUITING
Bordeaux
Hospices Civils de Lyon (HCL) - Hopital Pierre Wertheimer - Neurology
RECRUITING
Bron
CHU Lille Hopital Salengro - Neurology
RECRUITING
Lille
CHU Timone
RECRUITING
Marseille
Assistance Publique Hopitaux de Paris - Hopital Pitie-Salpetriere
RECRUITING
Paris
Centre Hospitalier Regional Universitaire de Strasbourg - Hopital de Hautepierre
RECRUITING
Strasbourg
Germany
Charite - Universitaetsmedizin Berlin
RECRUITING
Berlin
UKRUB - Berufsgenossenschaftliches Universitatsklinikum Bergmannsheil GmbH
RECRUITING
Bochum
Universitaetsklinikum Essen (AoR)
RECRUITING
Essen
Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITING
Milan
Japan
National Center Hospital, National Center of Neurology and Psychiatry
RECRUITING
Kodaira
National Hospital Organization Akita Hospital - Neurology
RECRUITING
Yurihonjō
Poland
Medicover Integrated Clinical Services (MICS) Centrum Medyczne Bydgoszcz
RECRUITING
Bydgoszcz
Centrum Medyczne Neurologia Slaska - Neurology
RECRUITING
Katowice
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
ACTIVE_NOT_RECRUITING
Warsaw
Spain
Hospital Sant Joan de Deu - Pediatric Neurology
RECRUITING
Esplugues De Llobregat
Hospital Universitario 12 de Octubre
RECRUITING
Madrid
Hospital Universitari i Politecnic La Fe
RECRUITING
Valencia
United Kingdom
Ulster Hospital
RECRUITING
Dundonald
Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital
RECRUITING
Oxford
Contact Information
Primary
Sabine Coppieters, MD
clinicaltrials@argenx.com
857-350-4834
Time Frame
Start Date: 2024-02-13
Estimated Completion Date: 2027-06
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: argenx

This content was sourced from clinicaltrials.gov